D
David M. Lurie
Researcher at University of Florida
Publications - 18
Citations - 684
David M. Lurie is an academic researcher from University of Florida. The author has contributed to research in topics: Radiation therapy & Clonogenic assay. The author has an hindex of 10, co-authored 17 publications receiving 586 citations. Previous affiliations of David M. Lurie include Veterinary Medical Teaching Hospital.
Papers
More filters
Journal ArticleDOI
Cisplatin: a review of toxicities and therapeutic applications.
TL;DR: Cisplatin is a platinum chemotherapeutic used in a variety of malignancies and has shown activity against osteosarcoma, transitional cell carcinomas, squamous cell carcinoma (SCC), melanoma, mesothelioma, carcinomatosis and germinal cell tumours in the dog and in the cat.
Journal ArticleDOI
Frameless stereotactic radiosurgery for the treatment of primary intracranial tumours in dogs.
Christopher L. Mariani,T. A. Schubert,R. A. House,M. A. Wong,Andrew L. Hopkins,H. L. Barnes Heller,Rowan J. Milner,Nola V. Lester,David M. Lurie,Didier A. Rajon,William A. Friedman,Frank J. Bova +11 more
TL;DR: Frameless SRS was used successfully to treat tumours in 51 dogs with a variety of head sizes and shapes and resulted in survival times comparable to conventional radiation therapy, but with fewer acute adverse effects and only a single anaesthetic episode required for therapy.
Journal ArticleDOI
Radiation therapy for canine appendicular osteosarcoma.
Alastair R. Coomer,James P. Farese,Rowan J. Milner,Julius M. Liptak,Nicholas J. Bacon,David M. Lurie +5 more
TL;DR: Palliative RT uses coarsely fractionated external beam RT or radiopharmaceuticals to provide relief of pain and lameness associated with OSA while resulting in minimal, if any, radiation-induced acute adverse effects.
Journal ArticleDOI
Immunophenotypic and cytomorphologic subclassification of T-cell lymphoma in the boxer breed.
TL;DR: The results of this study indicate that lymphoma in the boxer breed is a disease comprised predominantly of TCRalphabeta+, CD4+ (helper) T-cells with lymphoblastic (high-grade) morphology.
Journal ArticleDOI
Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009).
Christine E. Fahey,Rowan J. Milner,Karri Barabas,David M. Lurie,Kelvin Kow,Shannon Parfitt,Sarah E. Lyles,Monica Clemente +7 more
TL;DR: The University of Florida LOPP protocol may be an acceptable alternative to the mechlorethamine, vincristine, procarbazine, and prednisone protocol as a rescue protocol for dogs with lymphoma.